OFFICIAL-SOURCE RECALL · UNITED KINGDOM
Class 4 Medicines Defect Notification: Doncaster Pharma Limited Recall: of dosing errors arising from the
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
- Manufacturer
- See official notice
- Lot number
- batch-numbers, Batch
- Batch number
- numbers, Numbers
- Date code
- Date
- Expiration date
- Date
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
of dosing errors arising from the Braille issue. Advice for Patients: No action is needed from patients, continue to take medication from these batches of tablets. The actions will be controlled by the healthcare professionals who prescribe or dispense the medication who will provide appropriate support at the time of dispensing, where required. Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme . Additional information: For all medical information enquiries and information on this product, please email regulatory@doncasterpharma.co.uk or quality.enquiries@doncasterpharma.co.uk , or telephone 01302 365 000. For stock control enquiries, please email commercial@doncasterpharma.co.uk , or telephone 01302 365 000. Recipients of this Medicines Notification should bring it to the attention of relevant
Hazard
of dosing errors arising from the Braille issue. Advice for Patients: No action is needed from patients, continue to take medication from these batches of tablets. The actions will be controlled by the healthcare professionals who prescribe or dispense the medication who will provide appropriate support at the time of dispensing, where required. Patients who experience adverse reactions or have any questions about their medication should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme . Additional information: For all medical information enquiries and information on this product, please email regulatory@doncasterpharma.co.uk or quality.enquiries@doncasterpharma.co.uk , or telephone 01302 365 000. For stock control enquiries, please email commercial@doncasterpharma.co.uk , or telephone 01302 365 000. Recipients of this Medicines Notification should bring it to the attention of relevant
Official recall notice
Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
Agency: Medicines and Healthcare products Regulatory Agency
Official publication date: April 22, 2026
Read the official UK_MHRA recall notice →Scan products you own
Scan products you own once and let RecallGuard monitor future official recalls.
Scan & Monitor Products